实用癌症杂志
實用癌癥雜誌
실용암증잡지
THE PRACTICAL JOURNAL OF CANCER
2015年
1期
63-65
,共3页
经肝动脉灌注化疗栓塞术%单纯肝动脉灌注术%胃癌肝转移瘤
經肝動脈灌註化療栓塞術%單純肝動脈灌註術%胃癌肝轉移瘤
경간동맥관주화료전새술%단순간동맥관주술%위암간전이류
Hepatic artery chemoembolization%Simple hepatic arterial perfusion%Gastric cancer liver metastases
目的:比较经肝动脉灌注化疗栓塞术( TACE)与单纯肝动脉灌注术( TAI)治疗胃癌肝转移瘤的疗效。方法回顾性分析50例胃癌肝转移患者的临床资料。结果 TACE组有效率和控制率[76%(19/25)和92%(23/25)]均明显较TAI组[28%(7/25)和68%(17/25)]高(P<0.05);TACE组0.5、1、2生存率[92%(23/25)、56%(14/25)、16%(4/25)]均明显较TAI组[64%(16/25)、40%(10/25)、8%(2/25)]高(P<0.05);两组不良反应发生率[36%(9/25)、28%(7/25)]比较差异不显著( P>0.05)。结论经肝动脉灌注化疗栓塞术较单纯肝动脉灌注术治疗胃癌肝转移瘤的疗效好。
目的:比較經肝動脈灌註化療栓塞術( TACE)與單純肝動脈灌註術( TAI)治療胃癌肝轉移瘤的療效。方法迴顧性分析50例胃癌肝轉移患者的臨床資料。結果 TACE組有效率和控製率[76%(19/25)和92%(23/25)]均明顯較TAI組[28%(7/25)和68%(17/25)]高(P<0.05);TACE組0.5、1、2生存率[92%(23/25)、56%(14/25)、16%(4/25)]均明顯較TAI組[64%(16/25)、40%(10/25)、8%(2/25)]高(P<0.05);兩組不良反應髮生率[36%(9/25)、28%(7/25)]比較差異不顯著( P>0.05)。結論經肝動脈灌註化療栓塞術較單純肝動脈灌註術治療胃癌肝轉移瘤的療效好。
목적:비교경간동맥관주화료전새술( TACE)여단순간동맥관주술( TAI)치료위암간전이류적료효。방법회고성분석50례위암간전이환자적림상자료。결과 TACE조유효솔화공제솔[76%(19/25)화92%(23/25)]균명현교TAI조[28%(7/25)화68%(17/25)]고(P<0.05);TACE조0.5、1、2생존솔[92%(23/25)、56%(14/25)、16%(4/25)]균명현교TAI조[64%(16/25)、40%(10/25)、8%(2/25)]고(P<0.05);량조불량반응발생솔[36%(9/25)、28%(7/25)]비교차이불현저( P>0.05)。결론경간동맥관주화료전새술교단순간동맥관주술치료위암간전이류적료효호。
Objective To compare the efficacy of hepatic transarterial chemoembolization and hepatic transcatheter arte-rial infusion alone in the treatment of gastric cancer liver metastases.Methods The clinical data of 50 cases of gastric cancer pa-tients with liver metastases were retrospectively analyzed.Results The effective rate and control rate of hepatic transarterial che-moembolization group were 76%(19/25) and 92%(23/25),which were significantly higher than those of hepatic transcatheter arterial infusion group 28%(7/25) and 68%(17/25) (P<0.05);the 6-month,1-,2-year survival rates of hepatic transarterial chemoembolization group were 92%(23/25),56%(14/25),16%(4/25),which were significantly higher than those of hepatic transcatheter arterial infusion group 64%(16/25),40%(10/25),8%(2/25) (P<0.05);the differences of incidence rates of adverse reactions between the 2 groups 36%(9/25),28%(7/25) were not significant (P >0.05).Conclusion Hepatic transarterial chemoembolization has better effects than hepatic transcatheter arterial infusion alone in the treatment of gastric canc-er liver metastases.